1 year return (CAGR)
128.96%
Corvus Pharmaceuticals Inc Exchange (NASDAQ, USD)
CRVS
13.44
+1.02 (+8.21%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
104.13%
5 year return (CAGR)
43.10%
10 year return (CAGR)
-1.86%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.13B
Price/Sales
-
Ent value
1.13B
Price/Book
5.02
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-1.18%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 12.55 |
| Daily high | 13.46 |
| Daily low | 12.35 |
| Daily Volume | 805K |
| All-time high | 25.52 |
| 1y analyst estimate | 33.14 |
| Beta | 0.87 |
| EPS (TTM) | -0.59 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 5 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CRVS | S&P500 | |
| Current price drop from All-time high | -47.34% | -0.58% |
| Highest price drop | -96.97% | -56.47% |
| Date of highest drop | 28 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -68.64% | -10.68% |
| Avg time to new high | 94 days | 12 days |
| Max time to new high | 2216 days | 1805 days |
News
